Specifically, we wanted to determine the consequences of Slc6a14 deletion in LSL-KrasG12D/+; LSL-p53R172H/+; Pdx-1 Cre (KPC) mice in terms of PDAC growth, metastatic spread of the tumor, ascites fluid accumulation, and overall survival. The gene discussed is SLC6A14; the disease is neoplasm.